Hurricane Florence Notice: Potential Impact on NRG Oncology Research

NRG Oncology is keeping the US East Coast in our thoughts and hearts as Hurricane Florence approaches later this week.

We anticipate that the hurricane conditions will cause disruptions in the care of many cancer patients, including those enrolled on our trials as well as potential delays for drug distribution and data entry related to NRG Oncology studies.

We also realize that organizations involved in such functions as drug distribution for our trials may be affected and may announce their own contingency plans. As an example, McKesson Pharmacy has issued the following notice.

Please email us at should you have any questions.

On behalf of the entire group, NRG Oncology wishes for the safety and good health to all those affected by Hurricane Florence and honors the first responders, military, volunteers and other public servants deployed to help during this difficult time.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent to by
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Unsubscribe from all mailings Unsubscribe | Manage Subscription | Forward Email | Report Abuse